Parsolex was registered to exhibit at the CPhI North America Conference on September 9-11, 2020, in Philadelphia, PA.  Unfortunately, due to the global COVID-19 pandemic, the organizers of the event have made the difficult decision to cancel the live event as originally scheduled. The 2021 live conference has been scheduled for April 20-22, 2021, once again in Philadelphia, PA.

Despite the lost opportunity to meet in person at the CPhI North America Conference, we look forward to sharing about Parsolex’s recent investments to expand services for oral solid dosage forms from proof-of-concept through commercial scale.  We are ready and available to discuss innovations in pharmaceutical formulation, analytical development, CGMP manufacturing, and product commercialization.  Find out how our unique combination of science, engineering, and technology enables our team to deliver solutions to the most complex challenges facing the design, development, manufacturing, and supply of lifesaving medicines to patients around the world.

Please contact us to stay abreast of how Parsolex is evaluating to engage partners and potential clients in the near future!